Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 4,746 | 2,395 | 4,706 | 0 | 0 |
| Gross Profit | 4,746 | 2,395 | 4,706 | N/A | N/A |
| Operating Expenses | 20,996 | 25,779 | 21,265 | 56,468 | 25,457 |
| Operating Income | -16,250 | -23,384 | -16,559 | -53,966 | -25,457 |
| Interest Expense | 1,471 | 1,440 | 1,374 | 1,305 | 1,078 |
| Other Income | -99,366 | 226 | 311 | 193 | 8 |
| Pre-tax Income | -117,087 | -24,598 | -17,622 | -55,078 | -26,527 |
| Net Income Continuous | -117,087 | -24,598 | -17,622 | -55,078 | -26,527 |
| Net Income | $-117,087 | $-24,598 | $-17,622 | $-55,078 | $-26,527 |
| EPS Basic Total Ops | -0.93 | -0.38 | -0.28 | -0.96 | -0.65 |
| EPS Basic Continuous Ops | -0.93 | -0.38 | -0.28 | -0.96 | -0.65 |
| EPS Diluted Total Ops | -0.93 | -0.38 | -0.28 | -0.96 | -0.65 |
| EPS Diluted Continuous Ops | -0.93 | -0.38 | -0.28 | -0.96 | -0.65 |
| EBITDA(a) | $-15,919 | $-23,041 | $-16,228 | $-56,106 | $-25,180 |